Ideaya Biosciences Inc [IDYA] stock is trading at $23.63, up 7.31%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IDYA shares have gain 6.68% over the last week, with a monthly amount glided 10.32%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On June 26, 2025, Wells Fargo initiated with a Overweight rating and assigned a price target of $44 on the stock. Stephens started tracking the stock assigning a Overweight rating and suggested a price target of $51 on November 18, 2024. Leerink Partners downgraded its rating to a Market Perform but $27 remained the price target by the analyst firm on November 05, 2024. UBS started tracking with a Buy rating for this stock on October 24, 2024, and assigned it a price target of $50. In a note dated October 15, 2024, Cantor Fitzgerald initiated an Overweight rating.
Ideaya Biosciences Inc [IDYA] stock has fluctuated between $13.45 and $44.42 over the past year. Currently, Wall Street analysts expect the stock to reach $46.58 within the next 12 months. Ideaya Biosciences Inc [NASDAQ: IDYA] shares were valued at $23.63 at the most recent close of the market. An investor can expect a potential return of 97.12% based on the average IDYA price forecast.
Analyzing the IDYA fundamentals
Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -51.48%, Pretax Profit Margin comes in at -43.76%, and Net Profit Margin reading is -43.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.29 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.57 points at the first support level, and at 21.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.29, and for the 2nd resistance point, it is at 24.96.
Ratios To Look Out For
For context, Ideaya Biosciences Inc’s Current Ratio is 13.92. In addition, the Quick Ratio stands at 13.92 and the Cash Ratio stands at 2.56. Considering the valuation of this stock, the price to sales ratio is 295.65, the price to book ratio is 2.02.
Transactions by insiders
Recent insider trading involved Jason Throne, Former Officer, that happened on Aug 26 ’24 when 75000.0 shares were purchased.
